GABBR1 and Parkinson disease: Since the GABAergic system is involved in amphetamine-type stimulant use disorders [360] and because GABBR1 is associated with meth use disorder and relapse [361], GABBR1 might represent a pivotal factor linking meth abuse to PD pathogenesis.